Active ingredient
Tralokinumab NDC Codes
Tralokinumab is an active ingredient in 2 finished products listed with the FDA, under 1 name.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Adbry
- Labelers
- LEO Pharma Inc.
- Strengths
- Tralokinumab 300 mg/2mL; Tralokinumab 150 mg/mL
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Drug classes (FDA established)
- Interleukin-13 Antagonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 6
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Adbrytralokinumab-ldrm | Tralokinumab 300 mg/2mL | Injection, SolutionSubcutaneous | LEO Pharma Inc. | 50222-350 | 50222-0350-0150222-0350-0250222-0350-91 | — |
| Adbrytralokinumab-ldrm | Tralokinumab 150 mg/mL | Injection, SolutionSubcutaneous | LEO Pharma Inc. | 50222-346 | 50222-0346-0250222-0346-0450222-0346-92 | — |
Tralokinumab: common questions
- Which drugs contain Tralokinumab?
- Adbry.
- Is there a J-code for Tralokinumab?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.